Carbon Biosciences: Funding, Investors & Team (Sep 2026)
Carbon Biosciences is a biotech organization that takes part in the original parvovirus quality treatment.
Carbon Biosciences has raised $38.0M across 1 funding round on record, the most recent a Series A of $38.0M announced in Jun 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Carbon Biosciences Company Profile and Key Stats
Latest funding round on record: Jun 2022.
Carbon Biosciences Funding Rounds
Carbon Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Carbon Biosciences Funding Compared to Other Biotechnology Startups
Carbon Biosciences' latest round of $38.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Carbon Biosciences in Biotechnology and Lexington
Companies Similar to Carbon Biosciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Carbon Biosciences Funding FAQs
What does Carbon Biosciences do?
Carbon Biosciences is a biotech organization that takes part in the original parvovirus quality treatment.
How much funding has Carbon Biosciences raised?
Carbon Biosciences has raised $38.0M across 1 round on record. The most recent is a Series A of $38.0M announced in Jun 2022.
When did Carbon Biosciences last raise funding?
Carbon Biosciences' most recent funding round on record is a Series A of $38.0M, announced in Jun 2022.
Who is the CEO of Carbon Biosciences?
Joel Schneider is listed as CEO at Carbon Biosciences.
Where is Carbon Biosciences headquartered?
Carbon Biosciences is based in Lexington, Massachusetts, United States.
How many employees does Carbon Biosciences have?
Carbon Biosciences is in the 11-50 employee band.
How does Carbon Biosciences' funding compare to other Biotechnology startups?
Carbon Biosciences' latest round of $38.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Carbon Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Carbon Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.